Paraneoplastic syndromes in childhood neuroblastoma
DOI:
https://doi.org/10.12775/JEHS.2024.71.51252Keywords
neuroblastoma, paraneoplastic syndrome, opsoclonus-myoclonus syndrome, paraneoplastic diarrhea, paraneoplastic Cushing’s syndrome, paraneoplastic syndromesAbstract
INTRODUCTION: Neuroblastoma is a malignant tumor primarily affecting infants. Originating from embryonic cells of the sympathetic nervous system, NB commonly arises in the adrenal glands, followed by the abdomen, mediastinum, head, and neck. Clinical presentation varies depending on the tumor's location. General symptoms, if present, include fatigue, weight loss, and fever. The paraneoplastic syndrome refers to symptoms and disorders associated with malignant tumors but not directly caused by the tumor itself or its metastases. Opsoclonus-myoclonus syndrome and diarrhea are the most common paraneoplastic syndromes linked to neuroblastoma.
REVIEW METHODS: The article was conducted using PubMed and Google Scholar data concerning paraneoplastic syndromes associated with neuroblastoma.
THE STATE OF KNOWLEDGE: Opsoclonus-myoclonus syndrome is a neurological paraneoplastic syndrome that presents itself with characteristic eye movement disorder, short, involuntary, irregular twitches or spasms occurring in a muscle, sleep disturbance, and changes in behavior. Diarrhea resulting in hypokalemia may be also present as a paraneoplastic syndrome associated with neuroblastoma. Cushing’s syndrome is a rare condition in childhood, but it also may be linked to neuroblastoma.
CONCLUSIONS: Neuroblastoma is one of the most common childhood cancers, Paraneoplastic syndromes associated with neuroblastoma are rare conditions. Diagnosing chronic diarrhea, OMS, and Cushing's syndrome should always lead to the exclusion of neuroblastoma. Heightened awareness among pediatricians regarding PNS could result in faster diagnosis, timely treatment commencement, and ultimately enhance patient prognosis.
References
American Cancer Society. Cancer Facts & Figures 2020. Atlanta, Ga: American Cancer Society; 2020. Pages 12-13
Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010; 362: 2202-2211 DOI: 10.1056/NEJMra0804577
F Alexander. Neuroblastoma. Urol Clin North Am. 2000 Aug;27(3):383-92, vii. doi: 10.1016/s0094-0143(05)70087-2. DOI: 10.1016/s0094-0143(05)70087-2
Titilope A. Isholab, Dai H. Chunga. Neuroblastoma. Surg Oncol. 2007 Nov;16(3):149-56. doi: 10.1016/j.suronc.2007.09.005. Epub 2007 Oct 31.
Jerome B Posner. Paraneoplastic syndromes in neuroblastoma Pediatr Hematol Oncol 2004 DOI: 10.1097/01.mph.0000139454.22338.17
M El Shafie, D Samuel, C H Klippel, M G Robinson, B J Cullen. Intractable diarrhea in children with VIP-secreting ganglioneuroblastomas. Journal of Pediatric Surgery 1983;18:34–6 PMID: 6834224 DOI: 10.1016/s0022-3468(83)80269-3
M Espinasse-Holder, A S Defachelles, J Weill, Y De Keyzer, E M de Lasalle, B Nelken. Paraneoplastic Cushing syndrome due to adrenal neuroblastoma. Med Pediatr Oncol. 2000 Mar;34(3):231-3. DOI: 10.1002/(sici)1096-911x(200003)34:3<231::aid-mpo17>3.0.co;2-w
Luca Marsili, Samuel Marcucci, Joseph LaPorta, Martina Chirra, Alberto J Espay, Carlo Colosimo. Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment. Biomedicines. 2023 May 9;11(5):1406. DOI: 10.3390/biomedicines11051406
Maziar Emamikhah, Mansoureh Babadi, Mehrnoush Mehrabani, Mehdi Jalili, Maryam Pouranian, Peyman Daraie, Fahimeh Mohaghegh, Sharmin Aghavali, Maryam Zaribafian, Mohammad Rohani. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. J Neurovirol. 2021 Feb;27(1):26-34. DOI: 10.1007/s13365-020-00941-1
Bruno Giometto, Wolfgang Grisold, Roberta Vitaliani, Francesc Graus, Jérôme Honnorat, Guido Bertolini, Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010 Mar;67(3):330-5. DOI: 10.1001/archneurol.2009.341
F Graus, J Y Delattre, J C Antoine, J Dalmau, B Giometto, W Grisold, J Honnorat, P Sillevis Smitt, Ch Vedeler, J J G M Verschuuren, A Vincent, R Voltz. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1135-40. DOI: 10.1136/jnnp.2003.034447
Andreas Brunklaus, Keith Pohl, Sameer M Zuberi, Carlos de Sousa. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome. Arch Dis Child. 2012 May;97(5):461-3. DOI: 10.1136/adc.2010.204792
Michael R Pranzatelli, Elizabeth D Tate, Nathan R McGee. Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study. Front Neurol. 2017 Sep 11:8:468. DOI: 10.3389/fneur.2017.00468
E Rudnick, Y Khakoo, N L Antunes, R C Seeger, G M Brodeur, H Shimada, R B Gerbing, D O Stram, K K Matthay. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. Med Pediatr Oncol. 2001 Jun;36(6):612-22. DOI: 10.1002/mpo.1138
Mandy Hsu, Isbaah Tejani, Nidhi Shah, Rasaq Olaosebikan, Ashutosh Kumar, Sunil Naik. Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients. Children (Basel). 2024 Mar 19;11(3):367. DOI: 10.3390/children11030367
Junki Takenaka, Kenji Hirata, Shiro Watanabe, Hideaki Shiraishi, Kohsuke Kudo. Neuroblastoma-related severe hypoperfusion in the cerebellum of an infant: A case of opsoclonus-myoclonus syndrome. Asia Ocean J Nucl Med Biol. 2023;11(1):93-96.
DOI: 10.22038/AOJNMB.2022.65833.1459
Agnieszka Mizia-Malarz, Weronika Stolpa, Grażyna Sobol-Milejska. The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours-Single-Centre Experience and Literature Review. Medicina (Kaunas). 2020 Aug 14;56(8):412. DOI: 10.3390/medicina56080412
Michael R Pranzatelli, Elizabeth D Tate. Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome. Pediatr Neurol. 2017 Aug:73:48-56. DOI: 10.1016/j.pediatrneurol.2017.04.027
Armine Galstyan, Colin Wilbur, Kathryn Selby, Juliette Hukin. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis? Pediatr Neurol. 2017 Jul:72:65-69. DOI: 10.1016/j.pediatrneurol.2017.03.011
Marina Auconi, Laura Papetti, Claudia Ruscitto, Michela Ada Noris Ferilli, Fabiana Ursitti, Giorgia Sforza, Federico Vigevano, Massimiliano Valeriani. Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge. Children (Basel). 2021 Oct 26;8(11):965. DOI: 10.3390/children8110965
E De Grandis, S Parodi, M Conte, P Angelini, F Battaglia, C Gandolfo, A Pessagno, V Pistoia, W G Mitchell, M Pike, R Haupt, E Veneselli. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics. 2009 Jun;40(3):103-11. DOI: 10.1055/s-0029-1237723
Andreas Brunklaus, Keith Pohl, Sameer M Zuberi, Carlos de Sousa. Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life. Pediatrics. 2011 Aug;128(2):e388-94 DOI: 10.1542/peds.2010-3114
Thomas Rossor, E Ann Yeh, Yasmin Khakoo, Paola Angelini, Cheryl Hemingway, Sarosh R Irani, Gudrun Schleiermacher, Paramala Santosh, Tim Lotze, Russell C Dale, Kumaran Deiva, Barbara Hero, Andrea Klein, Pedro de Alarcon, Mark P Gorman, Wendy G Mitchell, Ming Lim. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective Neurol Neuroimmunol Neuroinflamm. 2022 Mar 8;9(3):e1153. DOI: 10.1212/NXI.0000000000001153
Poonam Bhatia, Jennifer Heim, Patricia Cornejo, Lauren Kane, Jason Santiago, Michael C Kruer. Opsoclonus-myoclonus-ataxia syndrome in children. J Neurol. 2022 Feb;269(2):750-757. DOI: 10.1007/s00415-021-10536-3
Alexis B Rothenberg, Walter E Berdon, Giulio J D'Angio, Darrell J Yamashiro, Robert A Cowles. The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review Pediatr Radiol. 2009 Jul;39(7):723-6. DOI: 10.1007/s00247-009-1282-x
Samuel Galgano, Stuart Royal. Primary pancreatic neuroblastoma presenting with opsoclonus-myoclonus syndrome. Radiol Case Rep. 2015 Nov 28;11(1):36-40. DOI: 10.1016/j.radcr.2015.09.003
Bill H Chang, Thomas Koch, Katharine Hopkins, Suman Malempati. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus. Pediatr Neurol. 2006 Sep;35(3):213-5. DOI: 10.1016/j.pediatrneurol.2006.02.008
João B Abreu, Catarina R Cordeiro, Ana I Amorim, Tiago G Catanho, Karina D Gama. Combined neuraxial-general anesthesia in opsoclonus-myoclonus syndrome: A case report. Saudi J Anaesth. 2023 Jan-Mar;17(1):94-96. DOI: 10.4103/sja.sja_558_22
Suvi Alikärri, Arimatias Raitio, Paul D Losty. Pre and postoperative diarrhoea associated with neuroblastoma resection - A systematic review of published studies. Eur J Surg Oncol. 2023 Oct;49(10):106921. DOI: 10.1016/j.ejso.2023.04.020
Mario Delgado, Doina Ganea. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids. 2013 Jul;45(1):25-39. DOI: 10.1007/s00726-011-1184-8
J Fahrenkrug. Transmitter role of vasoactive intestinal peptide. Pharmacol Toxicol. 1993 Jun;72(6):354-63. DOI: 10.1111/j.1600-0773.1993.tb01344.x
Anthony J Harmar, Jan Fahrenkrug, Illana Gozes, Marc Laburthe, Victor May, Joseph R Pisegna, David Vaudry, Hubert Vaudry, James A Waschek, Sami I Said. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012 May;166(1):4-17. DOI: 10.1111/j.1476-5381.2012.01871.x
C A Maggi, A Giachetti, R D Dey, S I Said. Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev. 1995 Apr;75(2):277-322. DOI: 10.1152/physrev.1995.75.2.277
S Linder, T Barkhem, A Norberg, H Persson, M Schalling, T Hökfelt, G Magnusson. Structure and expression of the gene encoding the vasoactive intestinal peptide precursor. Proc Natl Acad Sci U S A. 1987 Jan;84(2):605-9. DOI: 10.1073/pnas.84.2.605
Pradeep Kumar Siddappa, Santhi Swaroop Vege. Vasoactive Intestinal Peptide-Secreting Tumors: A Review. Pancreas. 2019 Oct;48(9):1119-1125. DOI: 10.1097/MPA.0000000000001402
Oana Belei, Diana-Georgiana Basaca, Elena Rodica Heredea, Emil Radu Iacob, Laura Olariu, Roxana Folescu, Andrei Gheorghe Marius Motoc, Anda-Maria Nanu, Otilia Mărginean. Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor.Life (Basel). 2023 Sep 27;13(10):1974. DOI: 10.3390/life13101974
Huysentruyt K., Arts W., van der Werff ten Bosch J., van de Casseye W., Lemmens F., de Koster J., Vandenplas Y., Van Damme A. VIP-Secreting Ganglioneuroblastoma as an Unusual Cause of Watery Diarrhoea in Childhood. J. Med. Cases. 2013;4:234–236. DOI: 10.4021/jmc1009w
Franck Bourdeaut 1, Emilie de Carli, Sandra Timsit, Carole Coze, Pascal Chastagner, Sabine Sarnacki, Olivier Delattre, Michel Peuchmaur, Hervé Rubie, Jean Michon. VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE).; Neuroblastoma Committee of the Société Française des Cancers et Leucémies de l'Enfant et de l'Adolescent. Pediatr Blood Cancer. 2009 May;52(5):585-90. DOI: 10.1002/pbc.21912
Wei Han, Huan-Min Wang. Refractory diarrhea: A paraneoplastic syndrome of neuroblastoma. World J Gastroenterol. 2015 Jul 7;21(25):7929-32. DOI: 10.3748/wjg.v21.i25.7929
Parshotam K Gera, Colin S Kikiros, Adrian Charles. Chronic diarrhoea: a presentation of immature neuroblastoma. ANZ J Surg. DOI: 10.1111/j.1445-2197.2007.04416.x
Benjamin Gesundheit, Charles R Smith, J Ted Gerstle, Sheila S Weitzman, Helen S L Chan. Ataxia and secretory diarrhea: two unusual paraneoplastic syndromes occurring concurrently in the same patient with ganglioneuroblastoma. J Pediatr Hematol Oncol. 2004 Sep;26(9):549-52. DOI: 10.1097/01.mph.0000139414.66455.a4
Constantine A Stratakis. An update on Cushing syndrome in pediatrics. Ann Endocrinol (Paris). 2018 Jun;79(3):125-131. Epub 2018 Apr 9. DOI:10.1016/j.ando.2018.03.010
M A Magiakou, G Mastorakos, E H Oldfield, M T Gomez, J L Doppman, G B Cutler Jr, L K Nieman, G P Chrousos. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med. 1994 Sep 8;331(10):629-36. DOI: 10.1056/NEJM199409083311002
Dalia L Batista 1, Jehan Riar, Meg Keil, Constantine A Stratakis. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics. 2007 Sep;120(3):e575-86. DOI: 10.1542/peds.2006-2402
Susmeeta T Sharma, Lynnette K Nieman 1, Richard A Feelders. Cushing's syndrome: epidemiology and developments in disease management. Clin Epidemiol . 2015 Apr 17:7:281-93. DOI: 10.2147/CLEP.S44336
Helen L Storr 1, Li F Chan, Ashley B Grossman, Martin O Savage. Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances. Trends Endocrinol Metab . 2007 May-Jun;18(4):167-74. DOI: 10.1016/j.tem.2007.03.005
Valentina Guarnotta, Fabrizio Emanuele, Riccardo Salzillo, Carla Giordano. Adrenal Cushing's syndrome in children. Front Endocrinol (Lausanne). 2023 Dec 12:14:1329082. DOI: 10.3389/fendo.2023.1329082
Maya B Lodish, Margaret F Keil, Constantine A Stratakis. Cushing's Syndrome in Pediatrics: An Update. Endocrinol Metab Clin North Am. 2018 Jun;47(2):451-462 DOI: 10.1016/j.ecl.2018.02.008
T Normann, J Havnen, O Mjolnerod. Cushing's syndrome in an infant associated with neuroblastoma in two ectopic adrenal glands. J Pediatr Surg. 1971 Apr;6(2):169-75. DOI: 10.1016/0022-3468(71)90313-7
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Natalia Małek, Sara Emerla, Aleksandra Brożyna, Anita Kwiatkowska, Arkadiusz Bydliński, Konrad Karłowicz, Maria Hermanowska, Julia Lubomirska, Patrycja Figurowska, Łukasz Ciulkiewicz, Patryk Pluta
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 392
Number of citations: 0